News

The candidate, R7128, is a prodrug of PSI-6130, an oral cytidine nucleoside analog polymerase inhibitor of HCV that is being developed through Pharmasset's collaboration with Roche. The Phase

Alvespimycin is a second-generation Hsp90 inhibitor that has demonstrated the potential to disrupt the activity of multiple oncogenes and cell signaling pathways implicated in tumor growth, including HER2,

Bristol, Tennessee-based King Pharmaceuticals said that it “intends to vigorously enforce the patent.” The patent extends through November 25, 2017. Under the federal Hatch-Waxman Act of 1984, any

Researchers also found that the antidepressant was associated with “significantly lower” adverse side effects. The study, funded by the National Institutes of Health and published in the online

The Phase IIb study is a randomized, double-blind, placebo-controlled study comparing 200mg 3x/day and 400mg 3x/day of bicifadine versus placebo, with a 1:1:1 randomization between the three arms,

Dr Jaap Goudsmit, Crucell's chief scientific officer, said: “Crucell's vaccine technologies, PER.C6 and AdVac, are increasingly used by the vaccine industry to develop important novel vaccines for infectious

Teva said that the court has issued an order temporarily enjoining the company from further sales of generic Famciclovir tablets, AB-rated to Novartis’s Famvir tablets. The injunction will

The first patient has been enrolled and dosed in the study. The trial is a randomized, double-blind and placebo-controlled dose-ranging trial to evaluate the efficacy of ABT-894 in

The agency’s observations led to the issuance of a warning letter on May 24, 2007. The UK facility is the bulk manufacturing site for FluMist (influenza virus vaccine